Most Recent
Neurim wins fight to amend patent for top-selling Circadin amid infringement case
Intellectual Property February 19, 2019 7:35 pm By Christine Caulfield

Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
ASIC asks High Court to clarify meaning of ‘officer’
Corporate January 16, 2019 9:58 pm By Miklos Bolza

ASIC is seeking approval from the High Court to appeal a judgment that let a former director of Gold Coast finance company MFS Group partially […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Toxic foam class action not time-barred, court hears
Class Actions January 10, 2019 10:36 pm By Cat Fredenburgh

The applicants in a class action¬†over exposure to allegedly toxic foam used on a government military base have struck back at the Commonwealth of Australia’s […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
MFS execs lose appeal over $147.5M in misused funds
Financial Services December 18, 2018 5:56 pm By Miklos Bolza

Three former executives of failed Gold Coast finance company MFS Group have lost their challenge to a ruling that they misappropriated $147.5 million in funds […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Neurim fights to amend Circadin patent amid infringement case against generics
Intellectual Property November 12, 2018 9:19 pm By Miklos Bolza

Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Privilege not waived by DLA Piper phone call over Circadin patent
Intellectual Property July 27, 2018 11:03 pm By Christine Caulfield

Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ amendments to patents covering sleep drug Circadin, with a court […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
DLA Piper’s patent advice to Neurim not privileged, court hears
Intellectual Property May 17, 2018 9:50 pm By Miklos Bolza

Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
DibbsBarker to close up shop following Dentons deal
Business of Law March 22, 2018 10:11 pm By Christine Caulfield

DibbsBarker is closing its doors after signing a deal that will see 17 partners and support staff move to Dentons, the world’s largest firm. The […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Dentons grows Aussie presence with new Melbourne digs
Dentons November 1, 2017 2:39 pm By Christine Caulfield

Global law firm Dentons has expanded its presence in Australia with a fifth office Down Under, this one in Melbourne. Responding to client demand for […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Competition lawyers brace for tougher enforcement
Competition & Consumer Protection October 31, 2017 12:06 pm By Christine Caulfield

Lawyers are advising large companies to look hard at their business plans to keep on the good side of the Australian Competition and Consumer Commission […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.